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Objective: Incident acute kidney injury and prevalent chronic
kidney disease are commonly encountered in septic patients. We
examined the differential effect of acute kidney injury and chronic
kidney disease on the association between cumulative fluid
balance and hospital mortality in critically ill septic patients.
Design: Retrospective cohort study.
Setting: Urban academic medical center ICU.
Patients: ICU adult patients with severe sepsis or septic shock
and serum creatinine measured within 3 months prior to and
72 hours of ICU admission. Patients with estimated glomerular
filtration rate less than 15 mL/min/1.73 m2 or receiving chronic
dialysis were excluded.
Interventions: None.
Measurements and Main Results: A total of 2,632 patients, 1,211
with chronic kidney disease, were followed up until hospital death or
discharge. Acute kidney injury occurred in 1,525 patients (57.9%),
of whom 679 (44.5%) had chronic kidney disease. Hospital mortality occurred in 603 patients (22.9%). Every 1-L increase in cumulative fluid balance at 72 hours of ICU admission was independently
associated with hospital mortality in all patients (adjusted odds
ratio, 1.06 [95% CI] 1.04–1.08; p < 0.001), and in each acute
kidney injury/chronic kidney disease subgroup (adjusted odds ratio,
1.06 [1.03–1.09] for acute kidney injury+/chronic kidney disease+;
1.09 [1.05–1.13] for acute kidney injury–/chronic kidney disease+;
1.05 [1.03–1.08] for acute kidney injury+/chronic kidney disease–;
and 1.07 [1.02–1.11] for acute kidney injury–/chronic kidney disease–). There was a significant interaction between acute kidney
injury and chronic kidney disease on cumulative fluid balance
(p =0.005) such that different cumulative fluid balance cut-offs with
the best prognostic accuracy for hospital mortality were identified:
5.9 L for acute kidney injury+/chronic kidney disease+; 3.8 L for
acute kidney injury–/chronic kidney disease+; 4.3 L for acute kidney
injury+/chronic kidney disease–; and 1.5 L for acute kidney injury–/
chronic kidney disease–. The addition of cumulative fluid balance
to the admission Sequential Organ Failure Assessment score had
increased prognostic utility for hospital mortality when compared
with Sequential Organ Failure Assessment alone, particularly in
patients with acute kidney injury.
www.ccmjournal.org
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Conclusions: Higher cumulative fluid balance at 72 hours of ICU
admission was independently associated with hospital mortality
regardless of acute kidney injury or chronic kidney disease presence. We characterized cumulative fluid balance cut-offs associated with hospital mortality based on acute kidney injury/chronic
kidney disease status, underpinning the heterogeneity of fluid
regulation in sepsis and kidney disease. (Crit Care Med 2016;
44:1891–1900)
Key Words: acute kidney injury; chronic kidney disease; cumulative
fluid balance; mortality; sepsis

S

epsis is the most common cause of ICU admissions and is
associated with significant morbidity and mortality (1, 2).
Acute kidney injury (AKI) is a frequent complication in
critically ill patients and occurs in nearly 45% of septic patients
and 60% of those with septic shock (3–5). The combination
of sepsis and AKI may synergistically increase mortality rates
to up to 50% (5–7). Most patients with sepsis have preexisting comorbidities, including chronic kidney disease (CKD) (1).
When compared with those without CKD, those with CKD have
a higher incidence and severity of sepsis, as well as increased
mortality from sepsis (8–10). CKD is now recognized as a relevant poor prognostic factor in patients with sepsis (11, 12).
Despite the known benefits of fluid therapy in sepsis
(13–15), the recognition of potential deleterious effects of
excessive fluid administration is alarming. Humphrey et al (16)
demonstrated a significant decrease in mortality with a fluidconservative resuscitation strategy in a small sample with acute
respiratory distress syndrome. More recently, Wiedemann et al
(17) showed that a fluid-conservative approach shortened the
duration of mechanical ventilation in patients with acute lung
injury. Subsequent studies have proposed “fluid accumulation”
or “positive fluid balance” as a marker of adverse outcomes in
patients with septic shock (2, 18, 19). Importantly, fluid overload (defined as fluid accumulation > 10% above baseline
weight) and mean daily fluid balance were independently associated with mortality in critically ill patients with AKI (20, 21).
Previous studies have not investigated the impact of cumulative fluid balance (CFB) on adverse outcomes based on incident
AKI and/or prevalent CKD stratification. The purpose of the
present study was to determine whether CFB was independently
associated with hospital mortality in critically ill septic patients
with or without incident AKI and prevalent CKD, and whether
a differential effect of AKI or CKD on this association could be
identified. We also investigated whether the addition of CFB to
the admission Sequential Organ Failure Assessment (SOFA) score
would improve the prognostic accuracy for hospital mortality.

MATERIALS AND METHODS
Study Design and Participants
We conducted a single-center, retrospective cohort study utilizing a database of patients with severe sepsis or septic shock
admitted to the ICU in an urban, tertiary care hospital. Study
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participants were identified using administrative-linked electronic databases for ICU admissions from May 2007 to April
2012. Severe sepsis or septic shock was defined by Angus et al
(1) criteria, using International Classification of Diseases, 9th
Revision, Clinical Modification (ICD-9-CM) codes (22) for
both a bacterial or fungal infection and a diagnosis of acute
organ dysfunction excluding gastrointestinal failure. We
included adult patients admitted from the emergency department (ED) to the ICU with a diagnosis of severe sepsis or septic
shock who had at least one serum creatinine (SCr) measured
and documented in the electronic medical records (EMRs) at
two different time points: within 3 months prior to and within
the first 72 hours of admission. Patients with absent or incomplete recorded daily fluid balance within the first 72 hours of
ICU stay and those with estimated glomerular filtration rate
(eGFR) of less than 15 mL/min/1.73 m2 or receiving chronic
dialysis were excluded. The protocol was approved by the institutional review board (7044).
Study Variables
Baseline SCr was defined as the most recent SCr within the
3-month period before ICU admission, which was used to calculate the baseline eGFR using the four-variable Modification
of Diet in Renal Disease (MDRD) study equation (23). Patients
were categorized as having AKI if the baseline SCr increased by
0.3 mg/dL or more or by 150% or more or required acute dialysis
as defined by Kidney Disease: Improving Global Outcomes SCrbased criteria (24). The highest SCr within 72 hours of admission
was used to determine the occurrence of AKI. Preexisting CKD
was defined as baseline eGFR of 15–59 mL/min/1.73 m2 in the
absence of chronic dialysis or end-stage renal disease.
CFB was calculated as follows: total fluid input minus total
fluid output within the first 72 hours of ICU stay. Subjectspecific variables were obtained from EMR. Acute Physiology
and Chronic Health Evaluation II (APACHE II) (25) and SOFA
(26) scores were calculated integrating clinical and laboratory
data from the first day of ICU admission. Oliguria was defined
as urine output less than 500 mL within 24 hours. Prevalent
comorbidity was identified using ICD-9-CM codes, except for
anemia that was defined as admission hematocrit less than
39% for men and less than 36% for women. Data pertaining
to drug exposure, RBC transfusion, mechanical ventilation,
and acute dialysis were based on hospital billing codes for the
indexed admission. All collected data were validated through
comprehensive individual review of 10% of EMR by data management personnel blinded to the study.
Study Outcome
The observation period was from admission to the ICU until the
time of hospital death or discharge. The primary outcome measure was all-cause hospital mortality, adjudicated based on EMR
review by data management personnel blinded to the study.
Statistical Analysis
The study sample was analyzed as a whole group and stratified into four subgroups by the occurrence of AKI (incident
October 2016 • Volume 44 • Number 10
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AKI) and preexisting CKD (prevalent CKD) as follows: AKI+/
CKD+, AKI–/CKD+, AKI+/CKD–, and AKI-/CKD–. Categorical data were reported as percentages and continuous data as
means ± sd or median [25th–75th percentile]. Comparisons
between groups for categorical variables were made using the
Fisher exact test. For continuous variables, analysis of variance
was used for Gaussian and Wilcoxon rank-sum test for nonGaussian distributed data.
Multivariable logistic regression models were constructed
for hospital mortality as the dependent variable and to evaluate CFB as an independent variable. The two-way interaction
between incident AKI and prevalent CKD (AKI × CKD) on CFB
and on hospital mortality was first evaluated in the entire cohort
to validate subgroup stratification if significant (p < 0.1). CFB
was modeled as a continuous variable (per 1-L increase) and
categorical variable (≥ vs < cut-off value). Optimal predicted
probability cut-offs were determined by Youden’s index from
receiver-operating characteristic (ROC) analysis. Candidate
variables for the multivariable models included demographic
data (age, gender, and race); comorbidities (diabetes, hypertension, heart failure, and anemia); indicators of critical illness
(SOFA and APACHE II scores, oliguria, mechanical ventilation,
RBC transfusion, and length of hospital stay [LOS]); and drug
exposure (vasoactive drug and diuretic). LOS was dichotomized
as greater than or equal to vs less than median value of 12 days.
Inclusion into the final model was based upon significance of
univariable results and clinical relevance. Only one of two variables was included in the event of collinearity between variables.
To test the model performance of CFB plus admission SOFA
score versus SOFA alone for the prediction of hospital mortality, ROC-areas under the curve were compared and continuous net reclassification index (NRI) and absolute integrated
discrimination improvement (IDI) were calculated (27). NRI
quantifies the hospital mortality events correctly reclassified
with the addition of CFB to the model that included SOFA
alone. IDI measures the increment in the predicted probabilities for the hospital mortality subset and the decrement for the
subset without hospital mortality. The 95% CI reported for
the logistic regression odds ratios (ORs) were based on Wald
estimation. Two-sided p values of less than 0.05 indicated statistical significance. Spreadsheet software and SAS 9.4 (SAS
Institute, Cary, NC) were used in data acquisition and analysis.
Sensitivity Analyses
CFB Adjustment by Body Weight. We adjusted CFB by ICU
admission body weight (W) in order to quantify fluid overload percentage (FO) using the following formula: FO = [(W
+ CFB/W) – 1] × 100%. FO was similarly evaluated as an independent variable in multivariable logistic regression models
for hospital mortality.
Multiple Imputation Method for Missing Baseline SCr
Values. A total of 3,070 patients had to be excluded from the
primary analysis because of absence of baseline SCr within
3 months prior to ICU admission. As a part of a sensitivity
analysis, these missing SCr values were imputed using a linear
regression model derived from subject-specific characteristics
Critical Care Medicine

of the primary study cohort (2,632 patients). Log-transformed
SCr was the dependent variable and independent predictors
included age, gender, race, diabetes, hypertension, APACHE
II score, and their interactions. The association between CFB
and hospital mortality was further evaluated in this secondary cohort of 5,688 patients (2,632 with known baseline SCr +
3,056 with imputed baseline SCr, after exclusion of 14 patients
with imputed baseline eGFR < 15 mL/min/1.73 m2) (28).
Propensity-Regression Analysis. The primary cohort logistic regression model of CFB (independent variable) and hospital mortality (dependent variable) included a continuous
propensity score as a covariate for statistical adjustment. This
propensity score was generated from all available study covariates that influenced the occurrence of AKI and/or CKD.
Standardized Mortality Ratio Determination to Examine
the Relationship Between CFB and Hospital Mortality. Standardized mortality ratio (SMR) for each AKI/CKD subgroup
by CFB quintiles was calculated as follows: SMR = observed/
predicted mortality; where predicted mortality was determined by the multivariable logistic regression estimate for
each AKI/CKD subgroup.

RESULTS
Clinical Characteristics
Of 6,490 patients admitted from the ED to the ICU with the
diagnosis of severe sepsis or septic shock, 3,858 were excluded
due to the following reasons: no recorded measures of baseline
SCr within 3 months before admission; incomplete CFB data
at 72 hours; or receiving chronic dialysis (Fig. 1). The primary
study cohort included 2,632 patients: 1,211 (46%) with preexisting CKD defined as an eGFR of 15–59 mL/min/1.73 m2 and
1,421 (54%) without CKD (eGFR ≥ 60 mL/min/1.73 m2). AKI
occurred in 1,525 patients (57.9%), 679 with pre-existing CKD
(44.5%) and 846 without CKD (55.5%) (Fig. 1). A total of 238
patients (9.0%) required acute dialysis for AKI.
Clinical characteristics of the cohort are reported in Table 1.
Patients who suffered from AKI, independently of CKD status,
had a higher frequency of pressor or inotrope requirement,
higher APACHE II and SOFA scores, and more frequent use
of mechanical ventilation (Table 1). The median LOS (25th–
75th percentile) was 12 days (7–21 d) in the entire cohort. In
the CKD group, LOS was not different based on the presence
of AKI, whereas in the non-CKD group, those with AKI had
a LOS of 12 days (7–20 d) when compared with those without AKI, 13 (8–22; p =0.01) (Table 1). Importantly, this difference was influenced by the observation that AKI patients who
died had shorter LOS than their non-AKI counterparts: 9 days
(4–19 d) versus 14 days (7–25 d), p = 0.007 (data not shown).
Study Outcomes
A total of 603 patients (22.9%) died during the observation
period, median LOS of 10 days (4–20 d). A higher proportion
of patients with AKI (28.1%) versus without AKI (15.8%) died
(p < 0.001). There was significant interaction between AKI and
CKD (AKI × CKD) on hospital mortality (p =0.04): 173 patients
www.ccmjournal.org
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were identified: 5.9 L for AKI+/
CKD+; 3.8 L for AKI–/CKD+;
4.3 L for AKI+/CKD–; and
1.5 L for AKI–/CKD–. The
CFB cut-off was lowest if both
AKI and CKD were absent
(Supplemental Table 1, Supplemental Digital Content 2,
http://links.lww.com/CCM/
B858). A stronger association
with hospital mortality was
found when CFB was tested as
a dichotomized variable (≥ vs
< cut-off value). The adjusted
ORs (95% CI) were as follows:
2.65 (1.70–4.12; p < 0.001) for
AKI+/CKD+; 2.34 (1.41–3.89;
Figure 1. Cohort derivation and study scheme. AKI = occurrence of acute kidney injury, CFB = cumulative
fluid balance, CKD = preexisting chronic kidney disease, eGFR = estimated glomerular filtration rate,
p =0.001) for AKI–/CKD+;
SCr = serum creatinine.
2.37 (1.60–3.50; p < 0.001) for
AKI+/CKD–; 2.61 (1.53–4.45;
with AKI (25.5%) versus 91 without AKI (17.1%) died in the p < 0.001) for AKI–/CKD– (Supplemental Fig. 2, SupplemenCKD group (p < 0.001) and 255 with AKI (30.1%) versus 84 tal Digital Content 3, http://links.lww.com/CCM/B859; legend, Supplemental Digital Content 5, http://links.lww.com/
without AKI (14.6%) died in the non-CKD group (p < 0.001).
CFB (mean ± sd) at 72 hours was higher in those who died: CCM/B861).
7.67 ± 7.94 versus 2.95 ± 6.05 L in survivors (p < 0.001). CFB was
also higher in those with AKI requiring dialysis (9.16 ± 8.91 L) Utility of CFB and SOFA Score for the Prediction of
than in those with AKI not requiring dialysis (4.61 ± 7.24 L) or Hospital Mortality
in those who did not suffer from AKI (2.80 ± 5.60 L; p for trend CFB at 72 hours was combined with the admission SOFA score
< 0.001). CFB was independently associated with hospital mor- in ROC plots for the prediction of hospital mortality in each
of the four AKI/CKD subgroups (Fig. 3). In all subgroups, the
tality in the entire cohort (adjusted OR per 1-L increase [95%
CI], 1.06 [1.04–1.08]; p < 0.001). The occurrence of AKI was an model (SOFA + CFB) significantly improved the predictive
independent predictor of hospital mortality (adjusted OR, 1.28 value for hospital mortality when compared with SOFA alone.
This observation was more pronounced in those patients who
[1.01–1.62]; p = 0.04) but preexisting CKD was not (p = 0.22).
There was a significant interaction between AKI and CKD (AKI suffered from AKI regardless of whether CKD was present or
absent. The model (SOFA + CFB) significantly improved the
× CKD) on CFB (p = 0.005) (Supplemental Fig. 1, Supplemental
Digital Content 1, http://links.lww.com/CCM/B857; legend, risk reclassification of hospital mortality over admission SOFA
score alone, as evident by NRI and IDI metrics (Table 3).
Supplemental Digital Content 5, http://links.lww.com/CCM/
B861). After subgroup stratification by incident AKI and prevalent CKD, univariable analyses revealed a significant association Sensitivity Analyses
between CFB and hospital mortality in all subgroups (Fig. 2A). After multiple imputation of missing baseline SCr values, a
secondary cohort of 5,688 patients was generated (2,632 with
After multivariable adjustment, every 1-L increase of CFB at 72
known baseline SCr + 3,056 with imputed baseline SCr). In
hours was independently associated with hospital mortality, with
this secondary cohort, results were essentially the same: CFB
adjusted ORs (95% CI) of 1.06 (1.03–1.09; p < 0.001) for AKI+/
was also independently associated with hospital mortality in
CKD+; 1.09 (1.05–1.13; p < 0.001) for AKI–/CKD+; 1.05 (1.03–
1.08; p < 0.001) for AKI+/CKD–; and 1.07 (1.02–1.11; p = 0.002) all patients, adjusted OR per 1-L increase (95% CI) 1.07 (1.06–
1.08; p < 0.001). After subgroup stratification by incident AKI
for AKI–/CKD– (Fig. 2A and Table 2). A similar association with
hospital mortality was found when CFB was adjusted by ICU and prevalent CKD, CFB at 72 hours was also independently
admission body weight (FO per 1% increase). The adjusted ORs associated with hospital mortality, adjusted ORs (95% CI)
(95% CI) were as follows: 1.04 (1.01–1.06; p = 0.005) for AKI+/ of 1.07 (1.05–1.09; p < 0.001) for AKI+/CKD+; 1.07 (1.04–
1.09; p < 0.001) for AKI–/CKD+; 1.05 (1.04–1.07; p < 0.001)
CKD+; 1.06 (1.03–1.10; p < 0.001) for AKI–/CKD+; 1.04 (1.02–
for AKI+/CKD–; and 1.07 (1.03–1.10; p < 0.001) for AKI–/
1.06; p < 0.001) for AKI+/CKD–; 1.05 (1.02–1.09; p = 0.003) for
CKD– (Supplemental Fig. 3A, Supplemental Digital Content
AKI–/CKD– (Fig. 2B).
4, http://links.lww.com/CCM/B860; legend, Supplemental
Digital Content 5, http://links.lww.com/CCM/B861). FurtherCFB Cut-Offs
more, this independent association persisted after adjustment
For each of the four AKI/CKD subgroups, different CFB cutby ICU admission body weight or FO (Supplemental Fig. 3B,
offs with the best prognostic accuracy for hospital mortality
1894
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Table 1. Patient Characteristics Stratified by Acute Kidney Injury/Chronic Kidney Disease
Subgroups
AKI+/CKD+
(n = 679)

AKI–/CKD+
(n = 532)

AKI+/CKD–
(n = 846)

AKI–/CKD–
(n = 575)

AKI × CKD
Interaction

Age (yr), mean ± sd

69.4 ± 14.2a

70.0 ± 14.8a

62.8 ± 15.8

61.5 ± 16.4

0.13

Women (%)

336 (49.5)

b

284 (53.4)

355 (42)

African-American (%)

261 (38.4)

b

178 (33.5)

Variable

Demographics
b
b

254 (44.2)

0.001

e

401 (47.4)

238 (41.4)

< 0.001

Chronic conditions
Baseline serum creatininef (mg/dL), mean ± sd

1.80 ± 0.66a

1.86 ± 0.73a

0.93 ± 0.24

0.92 ± 0.23

0.12

Baseline estimated glomerular filtration rate based
on Modification of Diet in Renal Disease Study
equationf (mL/min/1.73 m2), mean ± sd

41.7 ± 11.7

a

40.0 ± 12.5

93.4 ± 36.2

92.3 ± 29.7

0.04

Diabetes (%)

176 (25.9)b

136 (25.6)b

170 (20.1)

99 (17.2)

0.001

Hypertension (%)

181 (26.7)a,d

213 (40.0)b

432 (51.1)

297 (51.7)

< 0.001

18 (3.1)

0.36

Systolic heart failure (%)
Anemia (%)

a,e

30 (4.4)

15 (2.8)

600 (89)

25 (3)

455 (86.7)

722 (86.4)

488 (85.6)

0.26

45 (8.5)

66 (7.8)

55 (9.6)

0.12

151 (26.3)

< 0.001

Drug exposure (%)
Diuretic

47 (6.9)

Statin

257 (37.9)

a

185 (34.8)

211 (25)

Iodine contrast

103 (15.2)

115 (21.6)

222 (26.2)

199 (34.6)

< 0.001

Aminoglycoside

44 (6.5)

33 (6.2)

101 (11.9)

66 (11.5)

< 0.001

24 (5.6)

105 (14.7)d

16 (3.3)

0.002

5.55 ± 7.50

2.74 ± 5.31

0.005

4.0 ± 7.7

0.001

a,e

b

b
a

e

b

Critical indicators
Oliguria (%)

112 (20.2)c,d

Cumulative fluid balance (total fluid input minus
output within the first 72 hr of ICU admission)
(L), mean ± sd

4.16 ± 7.34

2.85 ± 5.91

5.7 ± 9.7b

4.7 ± 9.1

Fluid overload percentage 72 hr, %, mean ± sd
Length of hospital stay (d), median [25th-75th
percentile]
d

a,e

d

8.0 ± 11.1d

12.0 [6.0–21.0] 12.0 [7.0–20.0] 12.0 [7.0–20.0] 13.0 [8.0 –22.0]
b

0.07

e

Pressor or inotrope (%)

290 (42.7)d

144 (27.1)

366 (43.3)d

167 (29.0)

< 0.001

Mechanical ventilation (%)

297 (43.7)e

190 (35.7)

407 (48.1)e

219 (38.1)

< 0.001

19 (2.8)

19 (3.6)

29 (3.4)

18 (3.1)

0.77

14.5 ± 7.3

12.2 ± 5.8

11.1 ± 6.1

0.91

3.0 [1.0–6.0]

0.002

Blood transfusion (%)
Acute Physiology and Chronic Health Evaluation II
score, mean ± sd

d

b

Sequential Organ Failure Assessment score score,d 5.0 [3.0–9.0]d 4.0 [2.0–6.0]b
median [25th–75th percentile]

13.4 ± 6.9

e

5.0 [3.0–8.0]d

AKI = occurrence of acute kidney injury, CKD = preexisting chronic kidney disease.
CKD vs no CKD for the same AKI status, ap < 0.0001.
CKD vs no CKD for the same AKI status, bp < 0.01.
CKD vs no CKD for the same AKI status, cp < 0.05.
AKI vs no AKI for the same CKD status, dp < 0.0001.
AKI vs no AKI for the same CKD status, ep < 0.01.
f
Data were log-transformed before analysis. Comparisons for categorical variables were made using the Fisher Exact test. For continuous variables, analysis of
variance was used for Gaussian and Wilcoxon rank-sum test for non-Gaussian distributed data.
Anemia is defined as the hematocrit < 39% for men and < 36% for women; fluid overload percentage is defined as [(W + CFB/W)–1] × 100%, W is ICU
admission body weight; iodine contrast is defined as only if IV or intra-arterial; oliguria is defined as urine output < 500 mL in 24 hr.
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interaction between AKI/
CKD categories and CFB such
that for the first time, to our
knowledge, we characterized
different CFB cut-offs associated with hospital mortality
based on whether AKI and/or
CKD were present. Finally, we
showed that combining CFB
at 72 hours and admission
SOFA score improves the predictive value of the universally
accepted SOFA score for hospital mortality.
Fluid therapy in septic
shock consists of initial fluid
resuscitation followed by conservative fluid management
and regulation (29–32). The
inflammatory cascade of sepsis
is thought to disrupt the endothelial surface, alter the microvascular system, and cause
capillary leakage (33–35). Fluid
therapy may enhance filling
pressures and improve microcirculation in early sepsis but
not in late sepsis (15, 36). In
this context, detrimental consequences of fluid accumulation
in critically ill patients, including mortality, have been previously reported in acute lung
injury (17, 37), in sepsis (2, 38),
and in patients with AKI with
or without requirement for
dialysis (20, 21, 39–41).
Figure 2. Forest plots of unadjusted and adjusted odds ratios for hospital mortality in the primary cohort
(n = 2,632). A, Cumulative fluid balance (CFB) per 1-L increase at 72 hr of ICU admission. Adjusted odds ratio
An observational study
(95% CI) for hospital mortality in the entire cohort 1.06 (1.04–1.08); (B) fluid overload percentage (FO) per 1%
of
198 ICUs in 24 European
increase at 72 hr of ICU admission. Adjusted odds ratio (95% CI) for hospital mortality in the entire cohort 1.04
(1.03–1.06). AKI = occurrence of acute kidney injury; CKD = preexisting chronic kidney disease.
countries revealed that CFB
within the first 72 hours of
sepsis onset was directly assoSupplemental Digital Content 4, http://links.lww.com/CCM/
ciated with higher mortality, with an OR per 1-L increase of
B860; legend, Supplemental Digital Content 5, http://links.
1.1 (1.0–1.1; p = 0.001) (2). A secondary analysis of this study
lww.com/CCM/B861).
later reported that CFB was associated with increased mortalThe propensity-regression adjusted OR for hospital mortality ity specifically in the subgroup of patients with AKI (29). One
in the primary cohort was 1.09 (95% CI, 1.07–1.11; p < 0.001)
limitation of this study was that AKI was defined as a SCr of
for every 1-L increase in CFB at 72 hours. In addition, there was greater than 3.5 mg/dL (310 μmol/L) or urine output of less
a stepwise increase in SMR across CFB quintiles, evident in the
than 500 mL/d, and baseline SCr was not taken into considentire cohort and in each AKI/CKD subgroup (Fig. 4).
eration for AKI definition. Our investigation extends these
findings by using a more contemporary and accepted AKI defiDISCUSSION
nition taking the baseline SCr into account. Later, Bouchard
The principle new finding in our study is that the associaet al (20) reported that fluid overload defined as greater than
tion of higher CFB with hospital mortality is evident in all 10% increase in body weight was associated with 60-day morcritically ill septic patients, regardless of the occurrence of
tality in critically ill patients with AKI, with or without requireAKI and/or preexisting CKD. However, we found a significant ment for dialysis. Although this analysis did consider the
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Table 2. Multivariable Analysis of Hospital Mortality as the Dependent Variable and
Cumulative Fluid Balance as the Study Independent Variable in All Acute Kidney Injury/
Chronic Kidney Disease Subgroups
Clinical Variables

AKI+/CKD+
aOR (95% CI)

p

AKI–/CKD+
aOR (95% CI)

p

AKI+/CKD–
aOR (95% CI)

p

AKI–/CKD–
aOR (95% CI)

p

Cumulative fluid balance, per
1-L increase

1.06
(1.03–1.09)

< 0.001

1.09
(1.05–1.13)

< 0.001

1.05
(1.03–1.08)

< 0.001

1.07
(1.02–1.11)

0.002

Age, per 10-yrincrease

1.05
(0.91–1.22)

0.52

1.40
(1.16–1.68)

< 0.001

1.08
(0.96–1.21)

0.21

1.12
(0.96–1.30)

0.15

Sequential Organ Failure
Assessment, per 1-unit
score

1.07
(1.01–1.13)

0.02

1.08
(1.00–1.17)

0.04

1.05
(1.00–1.11)

0.05

1.08
(1.00–1.17)

0.07

Length of hospital stay, < 12
vs ≥12 d

0.70
(0.45–1.07)

0.10

0.74
(0.44–1.24)

0.26

0.57
(0.39–0.83)

0.003

1.02
(0.63–1.66)

0.94

Mechanical ventilation, yes
vs no

1.65
(1.02–2.65)

0.04

2.81
(1.58–4.99)

< 0.001

2.78
(1.82–4.24)

< 0.001

1.57
(0.90–2.73)

0.11

Oliguria, yes vs no

1.85
(1.11–3.08)

0.02

—

—

2.31
(1.42–3.75)

< 0.001

—

—

AKI = occurrence of acute kidney injury, CKD = preexisting chronic kidney disease, aOR = adjusted odds ratio.
Candidate variables for the multivariable models included demographic data (age, gender, and race); comorbidities (diabetes, hypertension, heart failure, and
anemia); indicators of critical illness (Sequential Organ Failure Assessment [SOFA] and Acute Physiology and Chronic Health Evaluation II [APACHE II] scores,
oliguria, mechanical ventilation, RBC transfusion, and length of hospital stay); and drug exposure (vasoactive drug and diuretic). Inclusion into the final model
(depicted in the Table 2) was based upon significance of univariable results (p < 0.10) and clinical relevance. APACHE II was not included in the multivariable
model because of collinearity with the SOFA score. No collinearity between cumulative fluid balance (CFB) and oliguria was detected in all subgroups
(variance inflation factor =1.0). Model C statistic (95% CI): 0.71 (0.65–0.76) for AKI+/CKD+, 0.75 (0.69–0.81) for AKI–/CKD+, 0.74 (0.69–0.78) for
AKI+/CKD–, and 0.67 (0.61–0.74) for AKI–/CKD–. Oliguria is defined as urine output < 500 mL in 24 hr.

baseline SCr in the definition of AKI, only patients for whom a
nephrology consultation for AKI was obtained were included,
which could have led to selection bias. In addition, a non-AKI
control group was not included for comparison, and the influence of preexisting CKD was not examined. Furthermore, fluid
overload was defined arbitrarily as the accumulation of fluid
from 3 days prior to nephrology consultation until hospital
discharge, which may not represent a uniform CFB estimate
in patients who develop AKI later in the course of ICU stay.
In contrast, we used a widely accepted definition for CFB as
net fluid accumulated over the first 72 hours of ICU stay. This
strategy has been previously tested (2) and provides clinically
useful information to more uniformly risk-stratify critically ill
septic patients using CFB as an additional clinical parameter.
More recently, Teixeira et al (41) confirmed the association
of higher fluid balance with mortality in ICU patients with
AKI and demonstrated higher CFB in nonsurvivors than in
survivors in the first 7 days of ICU stay. However, this study
included only 132 participants with AKI, and the adjudication
of AKI occurrence for the primary analysis was based on SCr
of greater than or equal to 3.5 mg/dL (310 μmol/L) or urine
output less than 500 mL/d, without the use of baseline SCr to
assess absolute or relative changes in SCr. Furthermore, recent
studies have shown that higher fluid overload at the time of
acute dialysis initiation for AKI was associated with 90-day
mortality (39) and worse renal recovery at 1 year (40).
Another important finding in our study was that patients
without preexisting CKD that did not develop AKI had
the lowest CFB and FO cut-offs associated with hospital
Critical Care Medicine

mortality. A possible explanation for this observation may be
that although in patients without kidney disease excess fluid is
usually self-regulated and excreted by preserved renal function,
this subgroup may be more susceptible to the negative consequences of acute fluid accumulation than those with preexisting CKD. Patients with CKD, particularly those with edema,
may have greater interstitial system adaptation to fluid overload than patients with preserved kidney function (42). The
adaptive response and compliance of the interstitial system
(43) can tolerate up to 4.5 L of excess total body fluid before
edema becomes evident on physical examination (44). Ebah
et al (45) demonstrated in patients with CKD stages 3 to 5
and obvious edema that both interstitial volume and pressure
were significantly increased in comparison with healthy volunteers. This observation may illustrate chronic fluid overload
adaptation (42). An additional observation was that FO cutoffs were all lower than the more than 10% FO cut-off associated with mortality previously reported in literature (20, 46,
47) (Supplemental Table 1, Supplemental Digital Content 2,
http://links.lww.com/CCM/B858). The heterogeneity of these
different cut-offs for adverse hospital outcomes in the context
of critical illness, sepsis, and kidney disease may be prognostically important but needs further investigation for validation.
The purpose of our study was to characterize this heterogeneity rather than to determine specific cut-offs that are readily
available for implementation in clinical practice.
Our study has important strengths that need to be delineated. First, we utilized universally accepted AKI and CKD
definitions, taking into consideration the baseline SCr. Second,
www.ccmjournal.org
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review of 10% of data. Finally,
unique to our study is the
stratification of participants
based on kidney disease status
(e.g., the occurrence of AKI
and preexisting CKD), and the
use of CFB both as continuous
and categorical independent
predictors.
Our study also has important limitations. First, we did
not have hourly urine output
data for all participants and
therefore did not use urine
output criteria for AKI adjudication. Nonetheless, we
included oliguria (urine output < 500 mL/d) as a potential
confounder in the multivariable models. Second, data pertaining to fluid administration
prior to ICU admission were
not available for inclusion in
the study. However, given that
the study subjects are from an
institution where standardized
goal-directed fluid resuscitation is generally practiced, we
can assume similar patterns of
pre-ICU fluid therapy for most
if not all participants. Third,
the determination of eGFR by
using the MDRD equation may
have led to overclassification of
CKD status in a small number
of patients although this would
have affected only less than 10%
of the cohort. Fourth, although
Figure 3. Receiver-operating characteristic plots representing the area under the curve (AUC) for the prediction of
we adjusted for confoundhospital mortality by the model of admission Sequential Organ Failure Assessment (SOFA) score + cumulative fluid
ing by rigorous multivariable
balance (CFB) at 72 hr (red), CFB at 72 hr (blue), and SOFA score (black). Comparison p values of SOFA + CFB vs
SOFA alone for each acute kidney injury (AKI)/chronic kidney disease (CKD) subgroup were calculated.
regression analyses, residual
confounding by unmeasured
covariates
may
not
have
been
completely
eliminated. Howbeit,
we adjusted the analyses for appropriate confounders, includdifferent
sensitivity
analyses,
including
propensity-regression
ing objective and comprehensive critical illness indicators.
analysis, confirmed our results.
Third, we demonstrated a significant interaction between AKI/
CKD categories and CFB and therefore justified our subgroup
stratification. Fourth, we characterize CFB cut-offs associated CONCLUSIONS
with hospital mortality in each AKI/CKD subgroup. Fifth, we
Higher CFB at 72 hours of ICU admission was indepenperformed rigorous sensitivity analyses: 1) CFB adjustment dently associated with hospital mortality in adult patients
by ICU admission body weight (FO); 2) imputation method with severe sepsis or septic shock, regardless of AKI or CKD
of missing values of baseline SCr to overcome the selecpresence. The combination of CFB at 72 hours and admistion bias inherent to the lack of these data in all participants; sion SOFA score improved the predictive value of SOFA
3) propensity-regression analysis; and 4) SMR determination score for hospital mortality. Stratification of patients by
to further examine the association between CFB relative to
the occurrence of AKI and preexisting CKD identified difbaseline and risk-adjusted hospital mortality. Sixth, the accuferent CFB cut-offs associated with hospital mortality,
racy of CFB data collection was validated by individual EMR
with the lowest CFB cut-off in those without incident AKI
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Table 3. Improvement in the Discrimination of Admission Sequential Organ Failure
Assessment Score for the Prediction of Hospital Mortality by Combining Sequential
Organ Failure Assessment Score + Cumulative Fluid Balance at 72 Hours in All Acute
Kidney Injury/Chronic Kidney Disease Subgroups
Model Performance Metric

AKI+/CKD+ (n = 679)

AKI–/CKD+ (n = 532)

AKI+/CKD– (n = 846)

AKI–/CKD– (n = 575)

Receiver-operating
characteristic area
under the curve
(95% CI)
CFB

0.70 (0.65, 0.75)

0.66 (0.60, 0.73)

0.68 (0.64, 0.72)

0.65 (0.58, 0.71)

SOFA

0.69 (0.64, 0.73)

0.66 (0.59, 0.72)

0.66 (0.62, 0.70)

0.63 (0.56, 0.70)

SOFA + CFB

0.74 (0.70, 0.79)

0.71 (0.64, 0.77)

0.72 (0.68, 0.75)

0.67 (0.60, 0.73)

pa SOFA vs SOFA + CFB

< 0.001

0.04

< 0.001

0.08

Continuous NRIb (95% CI)

0.53 (0.37, 0.70)

0.38 (0.16, 0.60)

0.46 (0.32, 0.61)

0.35 (0.13, 0.58)

NRI events correctly
reclassified

0.21 (0.15, 0.27)

0.01 (0.002, 0.06)

0.14 (0.10, 0.19)

0.07 (0.03, 0.15)

NRI nonevents correctly
reclassified

0.32 (0.28, 0.36)

0.37 (0.33, 0.42)

0.33 (0.29, 0.37)

0.28 (0.24, 0.32)

Absolute IDIc (95% CI)

0.052 (0.032, 0.072)

0.058 (0.028, 0.087)

0.053 (0.036, 0.070)

0.023 (0.008, 0.037)

IDI events

0.039 (0.019, 0.079)

0.047 (0.019, 0.113)

0.037 (0.020, 0.068)

0.019 (0.005, 0.076)

IDI nonevents

–0.013 (–0.028, –0.006) –0.010 (–0.024, –0.004) –0.016 (–0.03, –0.009) –0.003 (–0.014, –0.001)

AKI = occurrence of acute kidney injury, CFB = cumulative fluid balance (total fluid input minus output within the first 72 hr of ICU admission), CKD = preexisting
chronic kidney disease, IDI = integrated discrimination improvement, NRI = net reclassification index, SOFA = Sequential Organ Failure Assessment.
a
p value compares model receiver-operating characteristic area under the curve for Sequential Organ Failure Assessment (SOFA) + cumulative fluid balance
(CFB) vs SOFA alone. Net reclassification index and integrated discrimination improvement are presented as proportions.
b
Net reclassification index evaluates the incremental effect of adding CFB to SOFA score for the prediction of hospital mortality and quantifies the net number of
individuals reclassified correctly using the model of SOFA + CFB compared with SOFA alone with upward reclassification considered beneficial.
c
Absolute integrated discrimination improvement measures the increment in the predicted probabilities for the hospital mortality subset and the decrement for
the subset without hospital mortality between the model of SOFA + CFB vs SOFA alone.

or prevalent CKD. The characterization of different CFB
cut-offs underpins the heterogeneity of fluid regulation in
critical illness, sepsis, and kidney disease. These differences
should be further investigated in future prospective studies
in which measurements of interstitial volume and microcirculatory dynamics, in addition to intravascular volume, can
be used for guiding fluid therapy in critically ill patients with
or without kidney disease.
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Figure 4. Association between cumulative fluid balance relative to
baseline and risk-adjusted hospital mortality. Standardized mortality
ratio (SMR) for each acute kidney injury (AKI)/chronic kidney disease
(CKD) subgroup by cumulative fluid balance expressed as quintiles
was calculated as follows: SMR = observed/predicted mortality; where
predicted mortality was determined by the multivariable logistic regression
estimate for each AKI/CKD subgroup.
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